Journal of Medical Imaging and Radiation Oncology | 2019
Friday 18 October 2019
Abstract
References 1. Guckenberger M, andratschke N, Dieckmann K, Hoogeman MS, Hoyer M, Hurkmans C, et al. ESTRO ACROP consensus guideline on implementation and practice of stereotactic body radiotherapy for peripherally located early stage non-small cell lung cancer. Radiother Oncol [Internet]. 2017/07/09. Elsevier; 2017;124(1):11–7. Available from: https://www.ncbi.nlm.nih.gov/ pubmed/28687397 2. Haasbeek CJA, Palma D, Visser O, Lagerwaard FJ, Slotman B, Senan S. Early-stage lung cancer in elderly patients: A population-based study of changes in treatment patterns and survival in the Netherlands. Ann Oncol [Internet]. 2012;23 (10):2743–7. Available from: https://doi.org/10.1093/annonc/ mds081 3. Timmerman R, McGarry R, Yiannoutsos C, Papiez L, Tudor K, DeLuca J, et al. Excessive Toxicity When Treating Central Tumors in a Phase II Study of Stereotactic Body Radiation Therapy for Medically Inoperable Early-Stage Lung Cancer. J Clin Oncol [Internet]. 2006;24(30):4833–9. Available from: http://asc opubs.org/doi/abs/10.1200/JCO.2006.07.5937 4. Kong FM, Ritter T, Quint DJ, Senan S, Gaspar LE, Komaki RU, et al. Consideration of dose limits for organs at risk of thoracic radiotherapy: atlas for lung, proximal bronchial tree, esophagus, spinal cord, ribs, and brachial plexus. Int J Radiat Oncol Biol Phys [Internet]. 2010/10/12. 2011;81(5):1442–57. Available from: https://www.ncbi.nlm.nih.gov/pubmed/20934273 Friday 18 October 2019, 1030–1230, Concurrent Session 2.2.2 – Varian Prize